Drugmaker GlaxoSmithKline har preliminärt godkänt en 3 miljarder dollar uppgörelse över försäljning och marknadsföring praxis i flera av sina droger, inklusive diabetes drogen Avandia.

Sätter in Slutsatsen här:

Dr Mercola säger DU kan inte längre lita på vad de farmaceutiska bolagen gör, eller som Sidney M. Wolfe, director of Public Citizen's health research group säger detta kommer bara att fortsätta, så länge inte bötesbeloppen blir mycket större eller att de ansvariga direktörerna åker in i fängelse...

Folk litar på Läkaren som inte vet ett SKIT om medicinerna, sen äter patienterna mediciner och får sen hjärtinfarkt, och en massa andra allvarliga sjukdomar! Vad tycker du om detta?


Länk till Dr Mercola: http://www.mercola.com/

Länk: http://articles.mercola.com/sites/art ... e_cid=20111122_DNL_art_C4

As Sidney M. Wolfe, director of Public Citizen's health research group, told the Washington Post:

"The size of the penalties, although large, are not as large as the money [the drug companies] make and so they keep doing it over again …

The only way this is going to stop, or get reversed, is to greatly increase the size of the penalties or to start sending some of the executives to jail, if appropriate."


Bakgrund till GlaxoSmithKlines böter:

The Culmination of a Seven-Year Investigation

GlaxoSmithKline's $3-billion settlement is intended to bring a nearly decade-long legal saga to a close.

It started in 2004, when federal prosecutors began investigating the drug maker for marketing a handful of its drugs for unapproved uses, as well as the suspect techniques their reps used to influence doctors. The settlement also includes a U.S. Justice Department probe into potential Medicaid reimbursement fraud, as well as an investigation into the company's development and marketing of the Avandia diabetes drug.

After hitting the market in 1999, a 2007 study in the New England Journal of Medicine linked Avandia to a 43 percent increased risk of heart attack, and a 64 percent higher risk of cardiovascular death, compared to patients treated with other methods!

There were many articles and reviews published about Avandia following the New England Journal of Medicine study, but research from the Mayo Clinic revealed that 90 percent of scientists who wrote favorable articles about the drug had financial ties to GlaxoSmithKline.

Unfortunately, a committee of independent experts still recommended that Avandia remain on the market, despite its many risks, and a U.S. Food and Drug Administration (FDA) oversight board voted 8 to 7 to accept the advice.

Avandia works by making diabetic patients more sensitive to their own insulin, resulting in lower blood sugar levels. The problem is that despite clinically measurable improvement in blood sugar control following the use of this drug, hard outcomes associated with diabetes such as endothelial dysfunction and heart attack risk may actually worsen.

Why?

Because Avandia, like all pharmaceutical drugs, are synthetic chemicals and do not obey the same laws that natural substances do in your body (Remember: our body is composed of the natural things we have eaten and not chemicals). A simple change in the geometry of a molecule's "handedness" – i.e. whether it turns a beam of polarized light to the "left hand" or "right hand" -- can make the difference between endocrine correction and disruption; therapeutic activity and toxicity.

Although Avandia may correct a blood sugar imbalance by locking into the insulin receptors in a superficially beneficial way, it may also block out and/or disrupt many other processes in the body that can result in great harm.

Nature actually does the job much better anyway. In a 2009 study published in the Journal of Phytomedicine the herb and traditional food known as Bitter Melon was found to be superior to Avandia in the management of diabetes and its related complications.

It is also important to remember that type 2 diabetes is not caused by a lack of any drug, and that nutrition and lifestyle changes, as well as regular exercise holds the key to improving the health and well being of diabetics in a sustainable manner.

Despite the availability of alternative approaches, millions of people have been told to take Avandia and have been exposed to these unacceptably high-risk side effects. The statistics show that more than 80,000 diabetics have suffered from strokes, heart failure or other complications including lethal heart attacks from this dangerous drug.

It took nearly 10 years of the drug being on the market for the FDA to finally take action and restrict access to this dangerous drug, whereas the European Medicines Agency banned it altogether.

GlaxoSmithKline Covered up Negative Trial Data for 11 Years

As it turns out, GlaxoSmithKline spent 11 years covering up trial data that showed Avandia was a risky drug for the heart. In 1999, drugmaker SmithKline Beecham began a study to compare Avandia with another diabetes drug, Actos. The results showed that Avandia worked no better than Actos and had greater risks to the heart.

The study results were buried at the request of GlaxoSmithKline executives and were not reported to federal regulators, as is typically required by law.

In documents uncovered by the New York Times, the company stated they could lose $600 million from 2002 to 2004 if Avandia's heart risks were made public. The New York Times also obtained a sealed deposition that included testimony from Dr. Rosemary Johann-Liang, a former supervisor in the FDA's drug safety office who "left the FDA after she was disciplined for recommending that Avandia's heart warnings be strengthened."

GlaxoSmithKline not only hid negative study data, they also manipulated study data to fit their agenda.

According to the Times:

"An F.D.A. reviewer who closely examined a landmark Avandia clinical trial called "Record," found at least a dozen instances in which patients taking Avandia suffered serious heart problems that were not counted in the trial's tally of adverse events, mistakes that further obscured Avandia's heart risks."

Incidentally, a two-year long Senate investigation released in 2010 also found Avandia causes about 500 more heart attacks and 300 more cases of heart failure than Actos (Actos may also damage your heart -- just "not as much").

Drug Companies are the Thugs of the Medical World

No less than 19 drug companies made AllBusiness.com's Top 100 Corporate Criminals List for the 1990s -- which is par for the course when it comes to the drug giants. Fraud, bribery, illegal kick-backs and criminal activity are not at all unusual, and the fines and legal fees they eventually end up paying for their "get out of jail free card" are widely regarded as merely the cost of doing business.

Once you've been exposed to the seedy underbelly of the drug business—the LEGAL drug business—you can't but realize that we're dealing with a very large group of criminals and felons -- the thugs of the medical world. There's really no nicer way to put it.

What will really get your blood boiling, however, is how easily these companies are able to manipulate the system and get off scot-free for crimes that "ordinary" Americans would be sentenced to life in prison for committing.

For instance, Pfizer, which was found guilty of fraud many times over in 2009, should have been banned from dealing with Medicare and Medicaid again, as is automatically required for any company found guilty of fraudulent activity. But Pfizer is still doing business with these government programs because federal prosecutors allowed the drug giant to avoid being sentenced for massive fraud and deception by letting them form a sham company to take the fall.

So, in the end, Pfizer's "imaginary friend" Pharmacia & Upjohn shouldered the conviction, even though it had never sold any drugs. As CNN found, "the subsidiary is nothing more than a shell company whose only function is to plead guilty."

GlaxoSmithKline Whistleblower Reveals Company Knowingly Put Patients' Lives at Risk

In a 60 Minutes interview, whistleblower Cheryl Eckard reveals the gross negligence that occurred at the Cidra pharmaceutical plant, which is run by one of GlaxoSmithKline's subsidiaries. Eckard's quality assurance team uncovered numerous production problems, including failures on production lines that led to inconsistent dosages and employees contaminating products by not following procedures.

Worse yet, potent and potentially dangerous drugs were literally ending up in the wrong bottles! The antidepressant Paxil was mixed into bottles of Avandia. And Avandia was found in packages of the over-the-counter antacid Tagamet. All in all, Eckard identified nine different mix-ups of various drugs.

She urged the vice president of quality assurance for North America to stop the trucks from leaving the dock the day she discovered the mix-ups, and to shut down the factory and contact the FDA. But nothing happened… And, when one such mix-up was later discovered by a patient, GSK denied it ever happened. But "we all knew, they all knew it was real," said Eckard.

Finally, after eight months of reporting problems at the plant, Eckard sent a summary to seven executives detailing the numerous quality problems, warning that if the FDA knew of these issues, the plant would likely be seized.

Just weeks later, Eckard was out of a job. Concerned for the welfare of patients taking the affected drugs, she blew the whistle and notified the FDA. Federal agents searched the plant and seized hundreds of millions of dollars' worth of defective drugs. In the end, GlaxoSmithKline pleaded guilty to a felony: knowingly manufacturing and selling adulterated drugs, manufactured between 2001 and 2005.

But incredulously, their punishment amounted to only $150 million in criminal fines and $600 million in civil penalties -- not one single person in charge of the debacle went to jail!

Likewise with the current settlement, none of the actual people involved in this fraud and criminal activity -- which has taken the lives of innocent people -- are being held accountable. Companies can simply set aside billions of dollars to "deal with" their "legal issues" and continue on with their felonious behavior completely unfazed.

Of course, it certainly doesn't hurt that drug companies run the BIGGEST political lobby, and political lobbying is one of the primary reasons why the drug companies are controlling nearly the entire health industry, as well as many facets of the U.S. government.

In the CBS News video below, crooked lobbyist Jack Abramoff explains how he influenced Congress for years, and how this kind of corruption still continues.
-----------------------------------------------------------
Se bara Kalibers granskning: Biverkningar av läkemedel: De äldre är förlorarna:

http://sverigesradio.se/sida/artikel. ... gramid=83&artikel=4811774

Tänk så trasig världen kan bli när ingen gör ett hembesök.

Det blir så när dom ser att dom kan komma undan med vadsomhelst då gör dom ochså vad dom vill.

Folket har sig själva att beskylla.